🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 9 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/11/2017 | 81,17 | 83,21 | 81,14 | 83,01 | +2,33% | 2,55% | 287.739 |
| 21/11/2017 | 81,30 | 81,97 | 80,22 | 81,12 | -0,36% | 2,16% | 476.732 |
| 20/11/2017 | 84,85 | 85,00 | 79,33 | 81,41 | -6,99% | 6,69% | 1.441.578 |
| 17/11/2017 | 87,92 | 87,99 | 87,05 | 87,53 | -0,99% | 1,07% | 403.635 |
| 16/11/2017 | 89,93 | 90,34 | 87,84 | 88,40 | -1,83% | 2,78% | 642.162 |
| 15/11/2017 | 90,66 | 92,25 | 88,38 | 90,05 | -0,50% | 4,27% | 409.567 |
| 14/11/2017 | 88,90 | 90,66 | 87,68 | 90,50 | +1,59% | 3,35% | 466.954 |
| 13/11/2017 | 86,99 | 90,09 | 86,99 | 89,08 | +2,07% | 3,57% | 466.954 |
| 10/11/2017 | 90,05 | 90,39 | 86,16 | 87,27 | -3,42% | 4,70% | 1.125.146 |
| 09/11/2017 | 91,56 | 93,14 | 89,76 | 90,37 | -1,48% | 3,70% | 503.342 |
| 08/11/2017 | 91,14 | 92,48 | 91,14 | 91,73 | +0,23% | 1,47% | 235.160 |
| 07/11/2017 | 91,67 | 91,82 | 90,51 | 91,52 | -0,18% | 1,42% | 165.750 |
| 06/11/2017 | 91,67 | 91,78 | 90,97 | 91,68 | +0,36% | 0,89% | 207.428 |
| 03/11/2017 | 90,56 | 91,70 | 89,94 | 91,35 | +0,93% | 1,95% | 280.525 |
| 02/11/2017 | 89,68 | 90,90 | 88,66 | 90,51 | +0,71% | 2,50% | 210.795 |
| 01/11/2017 | 91,36 | 91,36 | 88,98 | 89,87 | -0,89% | 2,60% | 616.995 |
| 31/10/2017 | 89,62 | 90,74 | 89,15 | 90,67 | +1,70% | 1,78% | 328.775 |
| 30/10/2017 | 90,35 | 90,91 | 88,63 | 89,16 | -1,32% | 2,53% | 261.770 |
| 27/10/2017 | 89,10 | 90,93 | 88,47 | 90,35 | +1,19% | 2,77% | 383.277 |
| 26/10/2017 | 88,68 | 90,24 | 88,37 | 89,28 | +0,32% | 2,11% | 299.440 |
| 25/10/2017 | 89,58 | 89,90 | 87,99 | 89,00 | -0,60% | 2,13% | 258.885 |
| 24/10/2017 | 89,56 | 90,07 | 89,14 | 89,53 | +0,03% | 1,04% | 314.028 |
| 23/10/2017 | 89,81 | 90,22 | 89,08 | 89,51 | -0,31% | 1,27% | 214.161 |
| 20/10/2017 | 89,76 | 90,37 | 89,10 | 89,79 | +0,40% | 1,41% | 212.558 |
| 19/10/2017 | 89,37 | 90,02 | 88,91 | 89,43 | -0,56% | 1,24% | 287.418 |
| 18/10/2017 | 88,67 | 89,99 | 88,45 | 89,93 | +1,41% | 1,74% | 241.252 |
| 17/10/2017 | 88,53 | 89,13 | 88,33 | 88,68 | +0,29% | 0,90% | 188.353 |
| 16/10/2017 | 89,50 | 89,62 | 87,82 | 88,42 | -0,91% | 2,01% | 248.305 |
| 13/10/2017 | 89,51 | 89,76 | 88,66 | 89,23 | -0,22% | 1,23% | 292.708 |
| 12/10/2017 | 89,15 | 89,74 | 88,49 | 89,43 | +0,12% | 1,41% | 275.075 |